Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Alzheimer Dis Assoc Disord. 2010 Jan–Mar;24(1):43–48. doi: 10.1097/WAD.0b013e3181a6f101

Table 3.

Annualized volume loss in cc3 and annualized atrophy rates as a percent of baseline volume (standard deviations in parentheses)

Control (n=23) AD (n=12) FTD (n=13) SD (n=20)
Volume Δ % Δ Volume Δ % Δ Volume Δ % Δ Volume Δ % Δ
LFrontal 2.40 −1.3%
(3.1)
4.69 −2.8%
(3.6)
8.80 −6.3%
(9.2)
5.55 −3.2%
(2.9)
RFrontal 1.39 −0.8%
(2.8)
3.29 −1.8%
(4.0)
8.98 −6.1%
(6.5)
4.38 −2.4%
(2.5)
LTemporal 0.78 −0.7%
(2.1)
2.77 −2.9%
(2.5)
1.46 −1.5%
(4.3)
5.16 −5.9%
(3.0)
RTemporal 1.00 −0.9%
(2.1)
3.53 −3.5%
(2.8)
2.99 −3.1%
(3.5)
4.59 −4.8%
(2.9)
LParietal 0.03 ¥
(2.3)
2.64 −2.6%
(1.9)
0.87 −0.9%
(5.6)
2.31 −2.2%
(1.8)
RParietal 0.15 ¥
(2.6)
2.22 −2.2%
(2.7)
1.96 −1.7%
(6.2)
1.88 −1.7%
(1.9)

Note:

¥

<0.01% volume loss